Relates to the operation of gene synthesis providers and manufacturers of gene synthesis equipment

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 7 Sponsors

Jun 2, 2026 · Senate

SUBSTITUTED BY A3283C

May 21, 2026 · Senate

ADVANCED TO THIRD READING

May 20, 2026 · Senate

2ND REPORT CAL.

May 19, 2026 · Senate

1ST REPORT CAL.1239

Mar 13, 2026 · Senate

AMEND AND RECOMMIT TO HEALTH

Mar 13, 2026 · Senate

PRINT NUMBER 9279A

Feb 24, 2026 · Senate

REFERRED TO HEALTH

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Amended — base rate 13%, measured from NY's completed sessions
Momentum -2 41/100 from the pace of recorded action
Time since last action -19 133 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.